Document is current
Any future updates will be listed below
-
Authors
Gibson, Jessie S. https://orcid.org/0000-0003-4556-8428
Flanigan, Joseph L.
Patrie, James T.
Dalrymple, W. Alex
Harrison, Madaline B.
-
Funding
Funding for this research was provided by:
American Parkinson Disease Association
National Center for Advancing Translational Sciences (KL2TR003016/ULTR003015)
- License Information
-
More Information
Article History
Received: 6 July 2022
Accepted: 22 September 2022
First Online: 11 October 2022
Declarations
:
: This study was approved by University of Virginia’s Institutional Review Board, and it was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent.
: JSG has received additional research funding from University of Virginia; she has also received personal fees for consulting from Teva Branded Pharmaceutical Products, R&D, Inc. MBH reports clinical research grants from CHDI and Neurocrine, clinical program support from Huntington Disease Society of America and American Parkinson Disease Association, and personal fees for consulting from Huntington Study Group. JLF, JTP, and WAD have no conflicts to disclose.
